BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22615296)

  • 1. In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.
    Planche V; Ducroz S; Alanio A; Bougnoux ME; Lortholary O; Dannaoui E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4500-3. PubMed ID: 22615296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus.
    Seyedmousavi S; Meletiadis J; Melchers WJ; Rijs AJ; Mouton JW; Verweij PE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):796-803. PubMed ID: 23183435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.
    Perkhofer S; Jost D; Dierich MP; Lass-Flörl C
    Antimicrob Agents Chemother; 2008 May; 52(5):1873-5. PubMed ID: 18347112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
    Elefanti A; Mouton JW; Verweij PE; Tsakris A; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4656-63. PubMed ID: 23856768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
    Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
    Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Pfaller MA; Duncanson F; Messer SA; Moet GJ; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5155-8. PubMed ID: 21844312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Krishnan-Natesan S; Wu W; Chandrasekar PH
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
    Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed-ratio combination testing of an echinocandin, anidulafungin, and an azole, voriconazole, against 1,467 Candida species isolates.
    Jones RN; Castanheira M; Pfaller MA
    Antimicrob Agents Chemother; 2010 Sep; 54(9):4041-3. PubMed ID: 20547802
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
    Perea S; Gonzalez G; Fothergill AW; Kirkpatrick WR; Rinaldi MG; Patterson TF
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3039-41. PubMed ID: 12183266
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Raffetin A; Courbin V; Jullien V; Dannaoui E
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038263
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C; Valverde-Conde A; Chávez M M; Bernal S; Claro RM; Pemán J; Ramirez M; Martín-Mazuelos E
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
    O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
    J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rezafungin (CD101) demonstrates potent in vitro activity against Aspergillus, including azole-resistant Aspergillus fumigatus isolates and cryptic species.
    Wiederhold NP; Locke JB; Daruwala P; Bartizal K
    J Antimicrob Chemother; 2018 Nov; 73(11):3063-3067. PubMed ID: 30032217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    Buil JB; Brüggemann RJM; Bedin Denardi L; Melchers WJG; Verweij PE
    J Antimicrob Chemother; 2020 Sep; 75(9):2582-2586. PubMed ID: 32516368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
    Gao L; Ding X; Liu Z; Wu Q; Zeng T; Sun Y
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3813-6. PubMed ID: 26976874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.